JP4542757B2 - 縮合複素環化合物 - Google Patents

縮合複素環化合物 Download PDF

Info

Publication number
JP4542757B2
JP4542757B2 JP2003206492A JP2003206492A JP4542757B2 JP 4542757 B2 JP4542757 B2 JP 4542757B2 JP 2003206492 A JP2003206492 A JP 2003206492A JP 2003206492 A JP2003206492 A JP 2003206492A JP 4542757 B2 JP4542757 B2 JP 4542757B2
Authority
JP
Japan
Prior art keywords
group
carbon atoms
optionally substituted
isobutyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003206492A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004315496A5 (https=
JP2004315496A (ja
Inventor
悟 大井
博信 前▲ざき▼
孝治 池堂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority to JP2003206492A priority Critical patent/JP4542757B2/ja
Publication of JP2004315496A publication Critical patent/JP2004315496A/ja
Publication of JP2004315496A5 publication Critical patent/JP2004315496A5/ja
Application granted granted Critical
Publication of JP4542757B2 publication Critical patent/JP4542757B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2003206492A 2002-08-08 2003-08-07 縮合複素環化合物 Expired - Fee Related JP4542757B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003206492A JP4542757B2 (ja) 2002-08-08 2003-08-07 縮合複素環化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002231950 2002-08-08
JP2003051575 2003-02-27
JP2003206492A JP4542757B2 (ja) 2002-08-08 2003-08-07 縮合複素環化合物

Publications (3)

Publication Number Publication Date
JP2004315496A JP2004315496A (ja) 2004-11-11
JP2004315496A5 JP2004315496A5 (https=) 2006-08-17
JP4542757B2 true JP4542757B2 (ja) 2010-09-15

Family

ID=33479505

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003206492A Expired - Fee Related JP4542757B2 (ja) 2002-08-08 2003-08-07 縮合複素環化合物

Country Status (1)

Country Link
JP (1) JP4542757B2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
JP2006232819A (ja) * 2005-01-25 2006-09-07 Takeda Chem Ind Ltd シアノジヒドロピリジン化合物の製造方法
CN101128441A (zh) * 2005-03-04 2008-02-20 默克公司 具有抗糖尿病活性的稠合芳香化合物
SG10201404220TA (en) 2006-04-11 2014-10-30 Arena Pharm Inc Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
EP2108960A1 (en) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
AU2011237775A1 (en) 2010-04-06 2012-11-22 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
PH12013500547A1 (en) 2010-09-22 2013-06-10 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140018371A1 (en) 2011-04-01 2014-01-16 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140066369A1 (en) 2011-04-19 2014-03-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140038889A1 (en) 2011-04-22 2014-02-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145604A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
EA201791982A1 (ru) 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
AU2018249822A1 (en) 2017-04-03 2019-10-31 Coherus Biosciences Inc. PPArgamma agonist for treatment of progressive supranuclear palsy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW492957B (en) * 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase

Also Published As

Publication number Publication date
JP2004315496A (ja) 2004-11-11

Similar Documents

Publication Publication Date Title
US7547710B2 (en) Fused heterocyclic compounds as peptidase inhibitors
US7034039B2 (en) Fused heterocyclic compounds
JP4542757B2 (ja) 縮合複素環化合物
KR100858259B1 (ko) 디펩티딜 펩티다제 ｉｖ의 억제제로서의 피리딘 화합물
JP4213390B2 (ja) 縮合複素環化合物
US20060084690A1 (en) Isoxazole derivatives
WO2008044700A1 (en) GSK-3β INHIBITOR
AU2006217677A1 (en) Pyridyl acetic acid compounds
JP2006131559A (ja) 含窒素複素環化合物
JP2005194198A (ja) チエノピリジン化合物
CA2506735A1 (en) Indole derivatives as somatostatin agonists or antagonists
JP2000344748A (ja) ３−芳香族置換プロピオン酸またはアクリル酸化合物
JP4148672B2 (ja) イソオキサゾール誘導体
JP4473698B2 (ja) ピリジン化合物
RU2353617C2 (ru) Производные пиридина в качестве ингибиторов дипептидилпептидазы iv
JP4025345B2 (ja) ピリジル酢酸化合物
AU2002230126A1 (en) Fused heterocyclic compounds
JP2007224044A (ja) ピリジル酢酸化合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060703

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060703

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090909

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090915

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091015

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100427

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100607

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100622

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100628

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130702

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130702

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130702

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees